HFA Premium Access

MYK-491, a novel cardiac myosin activator, increases cardiac contractility in healthy volunteers

Congress Presentation

About the speaker

Doctor Jean-Francois Tamby

MyoKardia, South San Francisco (United States of America)
0 follower

56 more presentations in this session

Effects of mineralocorticoid ceceptor antagonists (MRA) in heart failure patients after up to 12 months of follow-up.

Speaker: Doctor L. Buttigieg (Msida, MT)

Thumbnail

Sacubitril valsartan, a multicentric experience

Speaker: Mr F. Cortes (Sevilla, ES)

Thumbnail

Reduction of NT-proBNP in patients with type 2 diabetes mellitus and heart failure with preserved ejection fraction in short-term treatment with empagliflozin on top of existing therapy

Speaker: Professor B. Kanazirev (Varna, BG)

Thumbnail

Effects of sacubitril/valsartan on real-world patients with heart failure due to non-ischemic cardiomyopathy

Speaker: Associate Professor C. Hsu (Taipei, TW)

Thumbnail

Effects of ivabradine on patients with depressed left ventricular ejection fraction after cardiac resynchronization therapy

Speaker: Doctor C. Hsieh (Taipei, TW)

Thumbnail

Access the full session

Poster Session 3 - Chronic Heart Failure – Treatment

Speakers: Doctor J. Tamby, Doctor L. Buttigieg, Mr F. Cortes, Professor B. Kanazirev, Associate Professor C. Hsu...
Thumbnail

About the event

Image

Heart Failure 2019

25 May - 28 May 2019

Sessions Presentations